Clinical Trial Update: Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids [Phase 3]

View source ↗

Summary

Phase 3 trial comparing denosumab with risedronate in individuals taking glucocorticoids; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• risedronate (risedronate)

Snippet

Sponsor: Amgen | Conditions: Steroid-induced Osteopor, Glucocorticoid-induced Ostepor | Phase 3 | Status: COMPLETED | Results posted: 2018-07-27